⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL373319 | 1.00 | — | — | |
| SCHEMBL8177707 | 1.00 | — | — | |
| SCHEMBL12921431 | 1.00 | — | — | |
| SCHEMBL12035111 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL740121 | 0.94 | — | — | |
| SCHEMBL15710308 | 0.94 | — | — | |
| SCHEMBL392083 | 0.94 | THRB (0.39) | — | |
| Hydrochloric Acid SCHEMBL374157 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL374156 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL14759257 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250079161-A1 | DEPOSITION OF ORGANIC MATERIAL | ASM IP HOLDING B.V. (NL) | 2025-03-06 | — | — | US | claimed |
| CN-119530765-A | Deposition of organic materials | ASM IP私人控股有限公司 | 2025-02-28 | — | — | CN | claimed |
| EP-2740738-B1 | PLATINUM COMPOUNDS FOR TREATING CELL PROLIFERATIVE DISEASE, PREPARATION METHODS AND USES THEREOF | BEIJING FSWELCOME TECH DEVELOPMENT CO LTD (CN) | 2018-03-28 | — | — | EP | claimed |
| US-20040087587-A1 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-05-06 | — | — | US | claimed |
| US-20040077645-A1 | Dipeptidyl aminopeptidase inhibitors; diabetes mellitus, arthritis, obesity, allograft transplantation and osteoporosis treatment | BOEHRINGER INGELHEIM PHARMA GMBH & CO KG (DE) | 2004-04-22 | — | — | US | claimed |
| US-20020198205-A1 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-12-26 | — | — | US | claimed |
| CN-119913498-A | Improved polymer inhibitors for regioselective deposition | ASM IP私人控股有限公司 | 2025-05-02 | — | — | CN | disclosed |
| US-20250137118-A1 | POLYMERIC INHIBITOR FOR AREA SELECTIVE DEPOSITION | ASM IP HOLDING B.V. (NL) | 2025-05-01 | — | — | US | disclosed |
| US-20250079161-A1 | DEPOSITION OF ORGANIC MATERIAL | ASM IP HOLDING B.V. (NL) | 2025-03-06 | — | — | US | disclosed |
| CN-119530765-A | Deposition of organic materials | ASM IP私人控股有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-117304687-B | Modified carbon fiber composite material and preparation method thereof | 江苏巨力特塑业科技股份有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-117304687-A | Modified carbon fiber composite material and preparation method thereof | 江苏巨力特塑业科技股份有限公司 | 2023-12-29 | — | — | CN | disclosed |
| US-20230348363-A1 | COMPOUNDS AND THEIR USE | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2023-11-02 | — | — | US | disclosed |
| US-5861398-A | Benzoperimidine-carboxylic acids and derivatives thereof | ALANEX CORPORATION (US) | 1999-01-19 | — | — | US | disclosed |
| US-5856065-A | BLEND CONTAINING PHOTOINITIATOR AND ORGANOSILICON COMPOUND | OLIN MICROELECTRONIC CHEMICALS, INC. (US) | 1999-01-05 | — | — | US | disclosed |
| CN-1179412-A | (E) -(R) -2 -alkyl -4 -(2, 2, 3, -trimethylcyclopent -3 -en -1 -yl) 2 -buten -1 -ol, process for preparing same, and use thereof | TAKASAGO PERFUMERY CO LTD (JP) | 1998-04-22 | — | — | CN | disclosed |
| WO-1998008821-A1 | BENZOPERIMIDINE-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF | AGOURON ACQUISITION CORP. (US) | 1998-03-05 | — | — | WO | disclosed |
| EP-0798597-A1 | Negative working photoresist composition based on polyimide primers | Olin Microelectronic Chemicals, Inc. (US) | 1997-10-01 | — | — | EP | disclosed |
| EP-0439688-A1 | 7-cycloalkylamino-6-fluoro-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid derivatives as antibacterial compounds | AMERICAN CYANAMID COMPANY (US) | 1991-08-07 | — | — | EP | disclosed |
| US-4992449-A | For treating bacterial infections | AMERICAN CYANAMID COMPANY (US) | 1991-02-12 | — | — | US | disclosed |